Login or Sign Up
16:01 Jan 19
Concord Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Concord Drugs Ltd. Deals
Concord Drugs Ltd.
Industry Pharmaceuticals
16:01 Jan 19
Quality
59/100
High Financial Strength
Valuation
41/100
Mid Valuation
Technical
58/100
Technically Neutral
Strength
6
Weakness
6
Opportunity
0
Threats
0
0.00 %
Dividend Yield
366.20
Market Cap (Cr)
48.7
RSI
54.39 %
Promoter Holding
0.74 %
Net Profit Margin
| Client | Date | Avg Price | Qty | Value(Cr) | Action |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully